VM-PATHI Correlates With Cognitive Function Improvement After Successful Treatment in Patients With Vestibular Migraine.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
01 09 2023
Historique:
medline: 18 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

To assess changes in cognitive function in vestibular migraine patients undergoing treatment. Prospective cohort. Single-institution tertiary-care center. Thirty-four patients with vestibular migraine were included in the study. Average age at diagnosis was 47.9 years. A majority of patients (91.2%) were female. Vestibular therapies included pharmacologic treatment (67.6%), mindfulness-based stress reduction (58.8%), vestibular physical therapy (20.6%), and lifestyle changes only (2.9%). Pretreatment and posttreatment questionnaires were collected including the Cognitive Failures Questionnaire (CFQ), Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI), and Dizziness Handicap Inventory. Median time between pretreatment and posttreatment questionnaire was 4.4 months (range, 2.8-15.6. mo). CFQ scores decreased in subjects who responded to treatment, as defined by those with a positive change in VM-PATHI score (average decrease, 6.5; p = 0.03). CFQ scores did not improve in subjects who had no improvement in their vestibular condition, as defined by no change or an increase in VM-PATHI score (average increase, 2.0; p = 0.53). Univariate linear regression showed that VM-PATHI score change was highly predictive of CFQ change ( p < 0.01, r2 = 0.36). Multivariate regression demonstrated that the VM-PATHI ( p = 0.03) and not the Dizziness Handicap Inventory ( p = 0.10) predicted changes in CFQ score. Self-reported cognitive dysfunction improves with successful treatment of vestibular migraine.

Identifiants

pubmed: 37525385
doi: 10.1097/MAO.0000000000003976
pii: 00129492-990000000-00358
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

813-816

Informations de copyright

Copyright © 2023, Otology & Neurotology, Inc.

Déclaration de conflit d'intérêts

The authors disclose no conflicts of interest.

Références

Zaag-Loonen HJ van der, Leeuwen RB van. Dizziness causes absence from work. Acta Neurol Belg 2015;115:345–349.
Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: The most frequent entity of episodic vertigo. J Neurol 2016;263(Suppl 1):82–9.
Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: A population-based survey study. Otol Neurotol 2018;39:1037–44.
Reploeg MD, Goebel JA. Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 2002;23:364–71.
Van Ombergen A, Van Rompaey V, Van de Heyning P, Wuyts F. Vestibular migraine in an otolaryngology clinic: Prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol 2015;36:133–8.
Rizk HG, Sharon JD, Lee JA, et al. Cross-sectional analysis of cognitive dysfunction in patients with vestibular disorders. Ear Hear 2020;41:1020–7.
Liu YF, Locklear TD, Sharon JD, et al. Quantification of cognitive dysfunction in dizzy patients using the Neuropsychological Vertigo Inventory. Otol Neurotol 2019;40:e723–31.
Donaldson LB, Yan F, Liu YF, Nguyen SA, Rizk HG. Does cognitive dysfunction correlate with dizziness severity in patients with vestibular migraine? Am J Otolaryng 2021;42:103124.
Harun A, Semenov YR, Agrawal Y. Vestibular function and activities of daily living: Analysis of the 1999 to 2004 National Health and Nutrition Examination Surveys. Gerontol Geriatr Med 2015;1:2333721415607124.
Sharon JD, Krauter R, Kirk L, et al. Development and validation of VM-PATHI: Vestibular Migraine Patient Assessment Tool and Handicap Inventory. Otol Neurotol 2020;41:e494–500.
Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982;21:1–16.
Rast P, Zimprich D, Van Boxtel M, Jolles J. Factor structure and measurement invariance of the Cognitive Failures Questionnaire across the adult life span. Assessment 2009;16:145–58.
Kramer AF, Humphrey DG, Larish JF, Logan GD, Strayer DL. Aging and inhibition: Beyond a unitary view of inhibitory processing in attention. Psychol Aging 1994;9:491–512.
Smith PF, Darlington CL, Zheng Y. Move it or lose it—Is stimulation of the vestibular system necessary for normal spatial memory? Hippocampus 2010;20:36–43.
Hitier M, Besnard S, Smith PF. Vestibular pathways involved in cognition. Front Integr Neurosci 2014;8:59.
Lopez C, Blanke O, Mast FW. The human vestibular cortex revealed by coordinate-based activation likelihood estimation meta-analysis. Neuroscience 2012;212:159–79.
Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain 2008;131:2538–52.
Popp P, Wulff M, Finke K, et al. Cognitive deficits in patients with a chronic vestibular failure. J Neurol 2017;264:554–63.
Redfern MS, Müller ML, Jennings JR, Furman JM. Attentional dynamics in postural control during perturbations in young and older adults. J Gerontol A Biol Sci Med 2002;57:B298–303.
Ghai S, Ghai I, Effenberg AO. Effects of dual tasks and dual-task training on postural stability: A systematic review and meta-analysis. Clin Interv Aging 2017;12:557–77.
Yogev-Seligmann G, Hausdorff JM, Giladi N. Do we always prioritize balance when walking? Towards an integrated model of task prioritization. Mov Disord 2012;27:765–70.
Danneels M, Van Hecke R, Keppler H, et al. Psychometric properties of cognitive-motor dual-task studies with the aim of developing a test protocol for persons with vestibular disorders: A systematic review. Ear Hear 2020;41:3–16.
Chari DA, Madhani A, Sharon JD, Lewis RF. Evidence for cognitive impairment in patients with vestibular disorders. J Neurol 2022;269:5831–42.

Auteurs

Evan J Patel (EJ)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco.

Maxwell Hum (M)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco.

Adam Gardi (A)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco.

Kristen K Steenerson (KK)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California.

Habib G Rizk (HG)

Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.

Jeffrey D Sharon (JD)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH